Announcements Trials
Browse Landscape

Phase

Phase 1 7Phase 1/2 6Phase 2 5Phase 3 2Phase 2/3 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Head & Neck 1Gynecologic 1Genitourinary 1Dermatologic 1

Conditions

Melanoma 18Carcinoma, Non-Small-Cell Lung 10Carcinoma, Renal Cell 9Kidney Neoplasms 4Stomach Neoplasms 3Mesothelioma 3Lung Neoplasms 3Diabetes Mellitus, Insulin-Dependent, 12 3Carcinoma, Hepatocellular 3Skin Neoplasms 2Prostatic Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Neoplasm Metastasis 2Mesothelioma, Malignant 2Head and Neck Neoplasms 2Colorectal Neoplasms 2Various Advanced Cancer 1Uveal Melanoma 1Uterine Cervical Neoplasms 1Urothelial Cancer 1Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma 1Recurrent Squamous Cell Lung Carcinoma 1Recurrence 1Non-Small Cell Lung Cancer Metastatic 1Neoplasms 1Melanoma, Cutaneous Malignant 1Lymphatic Metastasis 1

Interventions

Fluorouracil 131Leucovorin 127Oxaliplatin 93Bevacizumab 86Irinotecan 74Capecitabine 63Cetuximab 47Folfox protocol 32Panitumumab 18regorafenib 16trifluridine tipiracil drug combination 15Drug Therapy 14Chemotherapy, Adjuvant 13IFL protocol 10Floxuridine 10Radiotherapy 9Tegafur 7Neoadjuvant Therapy 7Levoleucovorin 7Laparoscopy 7Aspirin 7pembrolizumab 6atezolizumab 6Trifluridine 6Celecoxib 6XELOX 5Mitomycin 5Colonoscopy 5tipiracil 4sintilimab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Colorectal Neoplasms × Ipilimumab × Clear all
NCT04157985 2025-12-11

Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors

University of Pittsburgh

Phase 3 Completed
161 enrolled
DermatologicGastrointestinalGenitourinaryGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Kidney Neoplasms, Melanoma, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Cholangiocarcinoma

NCT04008030 2025-10-03

CheckMate 8HW

Bristol-Myers Squibb

Phase 3 Active not recruiting
839 enrolled 22 charts 1 FDA
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡